VINDIS, David, Martin HUTYRA, Daniel SANAK, Michal KRAL, Eva CECHAKOVA, Simona LITTNEROVÁ, Tomas ADAM, Jan PRECEK, Stepan HUDEC, Marketa JECMENOVA and Milos TABORSKY. Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, vol. 27, No 2, p. 357-364. ISSN 1052-3057. Available from: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.004.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Patent Foramen Ovale and the Risk of Cerebral Infarcts in Acute Pulmonary Embolism-A Prospective Observational Study
Authors VINDIS, David (203 Czech Republic), Martin HUTYRA (203 Czech Republic, guarantor), Daniel SANAK (203 Czech Republic), Michal KRAL (203 Czech Republic), Eva CECHAKOVA (203 Czech Republic), Simona LITTNEROVÁ (203 Czech Republic, belonging to the institution), Tomas ADAM (203 Czech Republic), Jan PRECEK (203 Czech Republic), Stepan HUDEC (203 Czech Republic), Marketa JECMENOVA (203 Czech Republic) and Milos TABORSKY (203 Czech Republic).
Edition JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, AMSTERDAM, ELSEVIER SCIENCE BV, 2018, 1052-3057.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.646
RIV identification code RIV/00216224:14110/18:00104069
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.09.004
UT WoS 000419585800019
Keywords in English Pulmonary embolism; patent foramen ovale; brain infarction; echocardiography; brain magnetic resonance imaging
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 17:15.
Abstract
Background: Pulmonary embolism (PE) is associated with a risk of consecutive paradoxical embolism with brain infarction through a patent foramen ovale (PFO). The aims of this study were to assess the rate of new ischemic brain lesions (IBLs) using magnetic resonance imaging (MRI) during a 12-month follow-up period with anticoagulation and to evaluate the potential relationship with the presence of PFO on transesophageal echocardiography (TEE). Subjects and Methods: Seventy-eight patients with acute PE underwent baseline contrast TEE with brain MRI. After the 12-month follow-up, 58 underwent brain MRI. The rates of MRI documenting new IBLs were measured based on the presence of PFO. Results: PFO was detected in 31 patients (39.7%). At baseline MRI, IBL was present in 39 of 78 patients (50%). The presence of IBL was not significantly higher in patients with PFO than in patients without PFO (20 [64.5% patients with PFO] versus 19 [40.4% without PFO] of 39 patients with baseline IBL, P = .063). At the follow-up MRI, in the group with new IBL (9 of 58 patients, 15.5%), the number of patients with PFO was significantly higher than that without PFO (7 [33.3%] versus 2 [5.4%], P = .008). PFO was identified as an independent predictor of new IBL (odds ratio 4.6 [1.6-47.4], P = .008). Conclusions: The presence of PFO was associated with new IBL in patients with PE. These patients are at a higher risk of ischemic stroke despite effective anticoagulation therapy.
PrintDisplayed: 24/7/2024 11:26